Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management
- PMID: 39229478
- PMCID: PMC11368823
- DOI: 10.1002/hsr2.70053
Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management
Abstract
Background and aims: Crimean-Congo Hemorrhagic Fever (CCHF) is a significant public health concern transmitted by ticks. This study seeks to thoroughly grasp the epidemiology and transmission patterns of CCHF, which is caused by the CCHF virus (CCHFV), a member of the Nairovirus genus in the Bunyaviridae family.
Methods: The study investigates the global distribution and endemicity of CCHF, its mortality rates, modes of transmission (including tick bites, contact with infected animal blood, and limited person-to-person transmission), and factors influencing its prevalence across different regions. Genetic diversity within CCHFV and its impact on transmission dynamics are explored, along with efforts to control the disease through tick prevention, antiviral treatment, and the development of vaccines and diagnostics.
Results: CCHFV exhibits widespread distribution, particularly in the Middle East, Africa, Asia, and Eastern Europe, with an overall mortality rate of approximately 30% and a case fatality rate ranging from 10% to 40%. Transmission occurs primarily through tick bites and contact with infected animal blood, with limited person-to-person transmission. Livestock workers, slaughterhouse employees, and animal herders in endemic areas are most affected by their frequent interaction with sick animals and ticks. Genetic diversity within CCHFV contributes to variations in transmission dynamics, complicating control efforts. Antiviral ribavirin shows efficacy in treating CCHF infection.
Conclusion: This study underscores the importance of further research to understand the enzootic environment, transmission routes, and genetic diversity of CCHFV for effective control measures, including the development of vaccines, treatment options, and diagnostics.
Keywords: outbreak investigation; pathophysiology; public health; vector‐borne diseases; viral hemorrhagic fevers; zoonotic diseases.
© 2024 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The current pathogenicity and potential risk evaluation of Crimean-Congo hemorrhagic fever virus to cause mysterious "Disease X"-An updated literature review.Health Sci Rep. 2024 Jun 24;7(6):e2209. doi: 10.1002/hsr2.2209. eCollection 2024 Jun. Health Sci Rep. 2024. PMID: 38915357 Free PMC article.
-
Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.Antiviral Res. 2013 Oct;100(1):159-89. doi: 10.1016/j.antiviral.2013.07.006. Epub 2013 Jul 29. Antiviral Res. 2013. PMID: 23906741 Review.
-
[Crimean-Congo hemorrhagic fever].Nihon Rinsho. 2016 Dec;74(12):2003-2007. Nihon Rinsho. 2016. PMID: 30550657 Japanese.
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
-
[Crimean-Congo hemorrhagic fever: basics for general practitioners].Med Trop (Mars). 2010 Dec;70(5-6):429-38. Med Trop (Mars). 2010. PMID: 21520641 Review. French.
Cited by
-
Emerging Arboviral Diseases in Pakistan: Epidemiology and Public Health Implications.Viruses. 2025 Feb 7;17(2):232. doi: 10.3390/v17020232. Viruses. 2025. PMID: 40006987 Free PMC article. Review.
References
-
- WHO . Crimean‐Congo Haemorrhagic Fever . Accessed February 22, 2024. https://www.who.int/news-room/fact-sheets/detail/crimean-congo-haemorrha...
-
- CDC . Crimean‐Congo Hemorrhagic Fever (CCHF) . 2023. Accessed April 14, 2024. https://www.cdc.gov/vhf/crimean-congo/index.html
LinkOut - more resources
Full Text Sources